VX1:ETR
Vertex Pharmaceuticals Inc
€455.80
arrow_downward
-0.51%(-2.35) 1D
Oct 13, 1:17:49 PM GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for VX1...
Open
€455.65
High
€457.85
Low
€455.65
Mkt. cap
128.50B
Avg. vol.
32.00
Volume
10.00
52-wk high
€480.40
52-wk low
€347.10
No. of employees
6K
Open
€455.65
High
€457.85
Low
€455.65
Mkt. cap
128.50B
Avg. vol.
32.00
Volume
10.00
52-wk high
€480.40
52-wk low
€347.10
No. of employees
6K
News stories
From web sources and news partners
Yahoo Finance
·
7 minutes ago
Moderna vs. Vertex Pharmaceuticals: Which Healthcare Stock Is a Better Buy in 2026?
The Globe and Mail
·
2 hours ago
Citi Sticks to Its Buy Rating for Vertex Pharmaceuticals (VRTX)
ad-hoc-news.de
·
2 hours ago
BofA cuts target for Vertex Pharma stock to USD 667.00
ad-hoc-news.de
·
22 hours ago
Vertex Pharma stock sits at EUR 459.90 with USD 130.1 billion market cap
Profile
Vertex Pharmaceuticals Incorporated is an American biopharmaceutical company based in Boston, Massachusetts. It was one of the first biotech firms to use an explicit strategy of rational drug design rather than combinatorial chemistry. It maintains headquarters in Boston, Massachusetts, and three research facilities, in San Diego, California, and Milton Park, Oxfordshire, England. Wikipedia
About Vertex Pharmaceuticals Inc
CEOReshma Kewalramani
Employees6.4K
Founded1989
HeadquartersBoston, Massachusetts, United States
SectorBiotechnology
Websitevrtx.com